background total correction of tetralogy of fallot (tof) anomaly in early childhood has been practiced in many centers with good results, but in some of patients after few years sever pulmonary valve insufficiency occurred. materials and methods at a cross- sectional study from january 2015 to january 2016, 10 patients who had history of primary repair of tof with free pulmonary insufficiency (...

concomitant coronary artery bypass surgery (cabg) in patients undergoing mitral valve replacement (mvr) has been shown to be an important risk factor for hospital mortality. we evaluated preoperative characteristics, postoperative complications, in-hospital mortality rate, and length of stay in hospital for patients undergoing concurrent cabg with mvr. preoperative and postoperative clinical da...

The Bjork-Shiley Monostrut valve is tilting disc mechanical valve prosthesis. This study was designed to present the long-term outcome of our experience. One hundred and thirty-seven Bjork-Shiley Monostrut valves were implanted in 101 consecutive patients from November 1983 to February 1990. There were 60 male and 41 female with mean age of 34.5 yr at the time of operation. Fifty-nine patients ...

BACKGROUND Long-term survival for combined aortic and mitral valve replacement appears to be determined by the mitral valve prosthesis from our previous studies. This 21-year retrospective study assess long-term outcome and durability of aortic valve replacement (AVR) with either concomitant mitral valve replacement (MVR) or mitral valve repair (MVrep). We consider only a single mechanical pros...

Background and Purpose: Candida endocarditis is an infrequent disease with a high mortality rate, which commonly occurs in immunosuppressed patients with cardiac valve replacement. We reported a 70-year-old woman diagnosed with Candida prosthetic valve endocarditis (PVE). This study also involved a review of all published cases of Candida PVE from 1970. Case report: Herein, we reported a 70-ye...

transcatheter aortic valve replacement (tavr) is a novel therapeutic intervention for the replacement of severely stenotic aortic valves in high-risk patients for standard surgical procedures. since the initial partner trial results, use of tavr has been on the rise each year. new delivery methods and different valves have been developed and modified in order to promote the minimally invasive p...

from may 1994 to december 1996 thirty patients received viable fresh aortic homografts. mean age was 55 years (13 to 70), male to female ratio was 2/1, 24 operations were elective whereas 6 were semiurgent. predominant lesions were aortic stenosis or regurgitation in lb patients, aortic valve endocarditis in 10, prosthetic valve dysfunction in 3, and aortic root pathology in one patient. from t...